Vaccines
Conference Coverage
NIH launches trial of Zika vaccine candidate
The phase I clinical trial began on Aug. 2 and will evaluate the safety and immunogenicity of an investigational DNA vaccine for Zika virus. If...
News
Zika virus RNA detected in serum beyond previously estimated time frame
In the one asymptomatic pregnant woman, Zika virus RNA was detected in serum at 53 days after her travel from an area with active Zika...
News
Approximately 9 million U.S. children, teens are vulnerable to measles infection
U.S. children younger than 3 years of age have a high estimated susceptibility to measles infection.
News
Influenza: A vaccine we love to hate
News
Coadministering a combined MMRV vaccine with MenC vaccine is immunogenic
Conference Coverage
Motivational interviewing for HPV vaccination well accepted by doctors
Nine months after motivational interviewing training, 72% of providers were still using the technique in HPV vaccine counseling.
News
Meningococcal B vaccine less protective than expected during outbreak
Key clinical point: The 4CMenB vaccine provided less protection than anticipated during an outbreak. Major finding: A total of 66.1% of vaccinated...
News
DTaP/IPV plus bivalent rLP2086 vaccine deemed noninferior in adolescents
Concomitant administration of the meningococcal serogroup B vaccine bivalent rLP2086 with the diptheria, tetanus, and acellular pertussis and...
News
HPV vaccination rates not improved by increased awareness
Increased awareness did not increase adolescent HPV vaccination rates in a high-risk population.